Recombinant DNA-based products are slow to reach the marketplace because of
A)the adverse effects of gene cloning.
B)the lack of technological advances in gene cloning.
C)the lack of safety involved in such methods.
D)the cost and duration of research.

Question

Quizplus · Accepted Answer

Recombinant DNA-based products require extensive research and development, including testing for safety and efficacy, which can be expensive and time-consuming. This delays their introduction into the marketplace. The adverse effects of gene cloning and lack of technological advances are less significant factors in the slow uptake of recombinant DNA-based products.

Recombinant DNA-Based Products Are Slow to Reach the Marketplace Because